 Evogliptin

Evogliptin (INN; trade name Suganon) is an antidiabetic drug in the dipeptidyl peptidase-4 (DPP-4) inhibitor or "gliptin" class of drugs.It was developed by the South Korean pharmaceutical company Dong-A ST and is approved for use in South Korea.